Developer docs
API playgroundTry for free, no card

Search company profiles

OnPoint Oncology

Full company profile

uuid000m29w

Namestring
OnPoint Oncology
Legal namestring
onPoint Oncology, Inc.
Company typeenum
Private
Founded yearint
2008
Descriptiontext

OnPoint Oncology, Inc., founded in 2008 by Tracy L. Lewis and headquartered in Hudson, Ohio, is a private Delaware-incorporated company that operates as a division of RXVantage. The company develops subscription-based market access and reimbursement intelligence products targeting the U.S. oncology market. Its flagship product, focalPoint, is a real-time, web-based data tool that tracks denials, payer policies, and payments at the clearinghouse level, enabling biotech and pharmaceutical manufacturers to identify challenges and opportunities in oncology drug reimbursement. The platform accrues claims data at the clearinghouse level for true match of inbound and outbound claims, and can track products with miscellaneous J-codes without algorithmic estimation, providing diagnosis-level detail.

The company complements focalPoint with three additional products: intelliPoint, a market research platform leveraging a proprietary panel of hematology/oncology physicians, practice administrators, and payers; assistPoint, which supports patient assistance and connectivity through oncology practices; and the Buy and Bill Guide, a self-service subscription educational resource for oncology practices covering coding, claim submissions, denials, and appeals. Underlying technology consists of a proprietary access and reimbursement database with clearinghouse-level data aggregation and real-time analytics, developed and refined over 17+ years by a small (1-10 employee) team.

OnPoint primarily targets enterprise biotech and pharmaceutical manufacturers via field sales, with secondary distribution to oncology practices and clinics. Revenue is generated through recurring annual subscriptions to focalPoint and intelliPoint (enterprise pricing not publicly disclosed) and self-serve subscriptions to the Buy and Bill Guide. The company's leadership draws heavily from oncology industry veterans, including Principal Roberta L. Buell, a nationally recognized oncology reimbursement expert with 23 years of experience presenting over 600 reimbursement seminars and publishing a monthly newsletter read by 4,700 subscribers. OnPoint operates without disclosed outside funding and within a tight geographic and operational footprint.

Short descriptiontext

OnPoint Oncology develops subscription-based market access and reimbursement intelligence products for U.S. biotech and pharmaceutical manufacturers in the oncology space, anchored by its focalPoint clearinghouse-level data platform and complemented by intelliPoint market research, assistPoint, and the Buy and Bill Guide. The company operates as a division of RXVantage from Hudson, Ohio.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
1–10
akta.pro rankint
HeadquartersHudson, United States
HQ citystring
Hudson
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
oncology reimbursement intelligence, market access analytics, buy-and-bill education, healthcare claims analytics, oncology market research
Industry2 codes
PRIMARYHLACAGAH
Oncology Pathways & Precision Medicine Decision Support
Healthcare & Life Sciences/Digital Health & Health IT/Clinical Decision Support (CDS) & Care Pathway Tools
SECONDARYHLACAEAI
Patient Financial Engagement (Estimates, Billing Presentment, Payments)
Healthcare & Life Sciences/Digital Health & Health IT/Patient Engagement, CRM & Experience Platforms
NAICS code1 code
  • Software Publishers513210
SIC code1 code
  • Services-Prepackaged Software7372
Product category
Oncology Reimbursement Intelligence
Social media profiles1 record
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model3 records
1focalPoint Subscription
TypeSubscription Recurring
Description

Real-time web-based subscription tool providing around-the-clock insight to denials, payer policy, and payments for provider-administered oncology products. Provides reimbursement intelligence with expert support and market access strategy guidance.

onpointoncology.com
2Buy and Bill Guide
TypeSubscription Recurring
Description

Comprehensive educational guide subscription providing ongoing buy-and-bill education and up-to-date reimbursement information via a website. Includes coding, billing, denials, appeals, Medicare and commercial payer guidance.

onpointoncology.com
3intelliPoint Market Research
TypeSubscription Recurring
Description

Qualitative and quantitative market research services with targeted, product-specific reporting. Includes War Room analysis for new drug launches and actionable reimbursement guides for pharmaceutical companies.

onpointoncology.com
Marketing channels4 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels2 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Personnel, Technology or R&D, Marketing or Sales, Operations, Others
Pricing details1 tier
1Enterprise subscription plans for pharmaceutical manufacturers
ModelSubscriptionBilling cadenceAnnual
Notes

Contact sales for pricing; subscription continues indefinitely until terminated

onpointoncology.com
GTM typeB2B
B2B
Offering typeSoftware
Software
Brand1 of 3 records shown
1focalPoint
Description

A distinctive product that accrues data at the clearing house level for a true match of inbound and outbound claims. Changes the way Biotech/Pharmaceutical manufacturers approach access and reimbursement by identifying opportunities and challenges with real-time data.

onpointoncology.com
+2 more records
Core offering1 text field

OnPoint Oncology develops and sells subscription-based software and data services that help biotech and pharmaceutical manufacturers, as well as oncology practices, navigate buy-and-bill oncology reimbursement. Its flagship product, focalPoint, provides real-time, web-based clearinghouse-level reimbursement intelligence on denials, payer policy, and payments for provider-administered oncology products, complemented by intelliPoint market research panels and the Buy and Bill Guide educational subscription.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 2 values shown
  • Consistently reduced time to payment and denial rates for supported products
+1 more record
Product overview1 text field

OnPoint Oncology offers a suite of specialized solutions for the oncology market, anchored by the core focalPoint platform—a real-time reimbursement intelligence tool. The portfolio includes the Buy and Bill Guide for educational content on medication acquisition and billing processes, and intelliPoint for qualitative and quantitative market research. These products work together to address access challenges for providers, patients, and life sciences companies in the complex oncology reimbursement landscape.

Product and service3 records
1focalPoint
CategoryReimbursement Intelligence
Description

Real-time, web-based reimbursement intelligence platform that aggregates data at the clearinghouse level to match inbound and outbound claims without algorithms, tracks miscellaneous J-code oncology products, and provides diagnosis-level detail on denials, payer policies, and payments for provider-administered oncology products. Sold by subscription to biotech and pharmaceutical manufacturers to support market access, payer marketing, and field sales teams.

2intelliPoint
CategoryMarket Research
Description

Market research service that provides intelligence-driven qualitative and quantitative research through a proprietary panel of influential hematology/oncology physicians, practice administrators, and payers, with targeted product-specific reporting, War Room analysis for new drug launches, and actionable reimbursement guides. Sold by subscription to life sciences companies and Hem/Onc brands.

3Buy and Bill Guide
Scale indicator2 records

Each record includes

Type, Value, Description, Source

Partnership1 partner
Strategic tierCoreTypeOthers
Description

RXVantage is the parent company of onPoint Oncology. onPoint Oncology operates as a division of RXVantage, leveraging shared technology platforms and organizational resources.

Recent move7 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight4 records

Each record includes

Type, Description

Peers10 records
TypeBroad incumbent
Description

IQVIA is the dominant healthcare data and analytics incumbent serving pharma with commercial effectiveness, market access, and real-world evidence solutions across all therapeutic areas including oncology.

2MMIT (Managed Markets Insight & Technology)
TypeDirect peer
Description

MMIT provides payer policy, formulary, and reimbursement intelligence to pharma manufacturers — directly overlapping focalPoint's core value proposition in market access data and coverage analytics. Both serve pharma access and reimbursement teams in oncology and specialty therapeutics.

TypeEmerging player
Description

Flatiron Health is an oncology-specific EHR and real-world data company serving both academic research and pharma commercial use cases, providing overlapping oncology data infrastructure for life sciences customers.

TypeBroad incumbent
Description

Cencora operates specialty pharmaceutical distribution and data services (including legacy ION Solutions and Oncology Supply) — closely tied to buy-and-bill oncology reimbursement workflows and overlapping with onPoint's provider and pharma audiences.

TypeEmerging player
Description

ConcertAI focuses on oncology real-world evidence and AI-driven clinical and commercial analytics for pharma and providers, partially overlapping with intelliPoint's market research and access strategy offerings.

6ZS Associates
TypeDirect peer
Description

ZS Associates operates a large pharma access and launch excellence practice with proprietary data assets serving oncology brand commercialization, including reimbursement strategy consulting and analytics for buy-and-bill products.

TypeDirect peer
Description

Integra Connect provides oncology practice management software, data analytics, and value-based care services to oncology practices and pharma manufacturers — overlapping with onPoint's provider-side buy-and-bill education and pharma intelligence offerings.

TypeBroad incumbent
Description

Syneos Health provides commercial and clinical services to pharma including market access and patient access support — adjacent to onPoint's pharma commercialization intelligence but with a broader service portfolio.

9McKesson (US Oncology Network)
TypeBroad incumbent
Description

McKesson operates the US Oncology Network and specialty distribution services for community oncology practices, including buy-and-bill workflow tools and manufacturer-facing analytics that overlap with onPoint's provider and pharma offerings.

TypeBroad incumbent
Description

Premier's PINC AI platform provides healthcare supply chain and clinical analytics; its specialty pharmacy and oncology benchmarking capabilities partially overlap with reimbursement and access analytics sold to pharma manufacturers.

Market position
Strengths4 records

Each record includes

Headline, Details, Source

Weaknesses4 records

Each record includes

Headline, Details, Source

Competitive moat5 records

Each record includes

Type, Details

Key risks5 records

Each record includes

Headline, Details, Source

Key highlights6 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers4 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment3 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile2 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature3 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles5 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

OnPoint Oncology

Oncology Reimbursement Intelligenceonpointoncology.com

OnPoint Oncology develops subscription-based market access and reimbursement intelligence products for U.S. biotech and pharmaceutical manufacturers in the oncology space, anchored by its focalPoint clearinghouse-level data platform and complemented by intelliPoint market research, assistPoint, and the Buy and Bill Guide. The company operates as a division of RXVantage from Hudson, Ohio.

What OnPoint Oncology does

OnPoint Oncology, Inc., founded in 2008 by Tracy L. Lewis and headquartered in Hudson, Ohio, is a private Delaware-incorporated company that operates as a division of RXVantage. The company develops subscription-based market access and reimbursement intelligence products targeting the U.S. oncology market. Its flagship product, focalPoint, is a real-time, web-based data tool that tracks denials, payer policies, and payments at the clearinghouse level, enabling biotech and pharmaceutical manufacturers to identify challenges and opportunities in oncology drug reimbursement. The platform accrues claims data at the clearinghouse level for true match of inbound and outbound claims, and can track products with miscellaneous J-codes without algorithmic estimation, providing diagnosis-level detail.

The company complements focalPoint with three additional products: intelliPoint, a market research platform leveraging a proprietary panel of hematology/oncology physicians, practice administrators, and payers; assistPoint, which supports patient assistance and connectivity through oncology practices; and the Buy and Bill Guide, a self-service subscription educational resource for oncology practices covering coding, claim submissions, denials, and appeals. Underlying technology consists of a proprietary access and reimbursement database with clearinghouse-level data aggregation and real-time analytics, developed and refined over 17+ years by a small (1-10 employee) team.

OnPoint primarily targets enterprise biotech and pharmaceutical manufacturers via field sales, with secondary distribution to oncology practices and clinics. Revenue is generated through recurring annual subscriptions to focalPoint and intelliPoint (enterprise pricing not publicly disclosed) and self-serve subscriptions to the Buy and Bill Guide. The company's leadership draws heavily from oncology industry veterans, including Principal Roberta L. Buell, a nationally recognized oncology reimbursement expert with 23 years of experience presenting over 600 reimbursement seminars and publishing a monthly newsletter read by 4,700 subscribers. OnPoint operates without disclosed outside funding and within a tight geographic and operational footprint.

OnPoint Oncology firmographics

Firmographics
Name
OnPoint Oncology
Legal name
onPoint Oncology, Inc.
Website
https://onpointoncology.com
Company type
Private
Founded year
2008
Operating status
Operating
Headcount range
1–10 employees
Short description
OnPoint Oncology develops subscription-based market access and reimbursement intelligence products for U.S. biotech and pharmaceutical manufacturers in the oncology space, anchored by its focalPoint clearinghouse-level data platform and complemented by intelliPoint market research, assistPoint, and the Buy and Bill Guide. The company operates as a division of RXVantage from Hudson, Ohio.
Ownership category
akta.pro rank

OnPoint Oncology industry classification

Industry
Product category
Oncology Reimbursement Intelligence
NAICS
Software Publishers (513210)
SIC
Services-Prepackaged Software (7372)
akta.pro industry
PRIMARYHLACAGAH
Oncology Pathways & Precision Medicine Decision Support
Healthcare & Life Sciences/Digital Health & Health IT/Clinical Decision Support (CDS) & Care Pathway Tools
SECONDARYHLACAEAI
Patient Financial Engagement (Estimates, Billing Presentment, Payments)
Healthcare & Life Sciences/Digital Health & Health IT/Patient Engagement, CRM & Experience Platforms

Keywords

  • Oncology reimbursement intelligence
  • Market access analytics
  • Buy-and-bill education
  • Healthcare claims analytics
  • Oncology market research

Where OnPoint Oncology is headquartered

Location

Headquarters

HQ city
Hudson
HQ country
United States
HQ region
North America

Offices1 record

Markets served

OnPoint Oncology business model

Business model
GTM type
B2B
Offering type
Software
Cost components
Personnel, Technology or R&D, Marketing or Sales, Operations, Others

Revenue model

  1. focalPoint Subscription: Real-time web-based subscription tool providing around-the-clock insight to denials, payer policy, and payments for provider-administered oncology products. Provides reimbursement intelligence with expert support and market access strategy guidance.
  2. Buy and Bill Guide: Comprehensive educational guide subscription providing ongoing buy-and-bill education and up-to-date reimbursement information via a website. Includes coding, billing, denials, appeals, Medicare and commercial payer guidance.
  3. intelliPoint Market Research: Qualitative and quantitative market research services with targeted, product-specific reporting. Includes War Room analysis for new drug launches and actionable reimbursement guides for pharmaceutical companies.

Pricing tiers

ModelBillingPrice
SubscriptionAnnualEnterprise subscription plans for pharmaceutical manufacturers

Go-to-market motion1 record

Distribution channels2 records

Marketing channels4 records

OnPoint Oncology product offering

Product offering

Core offering

OnPoint Oncology develops and sells subscription-based software and data services that help biotech and pharmaceutical manufacturers, as well as oncology practices, navigate buy-and-bill oncology reimbursement. Its flagship product, focalPoint, provides real-time, web-based clearinghouse-level reimbursement intelligence on denials, payer policy, and payments for provider-administered oncology products, complemented by intelliPoint market research panels and the Buy and Bill Guide educational subscription.

Product overview

OnPoint Oncology offers a suite of specialized solutions for the oncology market, anchored by the core focalPoint platform—a real-time reimbursement intelligence tool. The portfolio includes the Buy and Bill Guide for educational content on medication acquisition and billing processes, and intelliPoint for qualitative and quantitative market research. These products work together to address access challenges for providers, patients, and life sciences companies in the complex oncology reimbursement landscape.

Differentiator

Problem solved

Functional benefit

Brands

  • focalPoint: A distinctive product that accrues data at the clearing house level for a true match of inbound and outbound claims. Changes the way Biotech/Pharmaceutical manufacturers approach access and reimbursement by identifying opportunities and challenges with real-time data.
  • Buy and Bill Guide
  • intelliPoint

Products and services

  • focalPoint Real-time, web-based reimbursement intelligence platform that aggregates data at the clearinghouse level to match inbound and outbound claims without algorithms, tracks miscellaneous J-code oncology products, and provides diagnosis-level detail on denials, payer policies, and payments for provider-administered oncology products. Sold by subscription to biotech and pharmaceutical manufacturers to support market access, payer marketing, and field sales teams.
  • intelliPoint Market research service that provides intelligence-driven qualitative and quantitative research through a proprietary panel of influential hematology/oncology physicians, practice administrators, and payers, with targeted product-specific reporting, War Room analysis for new drug launches, and actionable reimbursement guides. Sold by subscription to life sciences companies and Hem/Onc brands.
  • Buy and Bill Guide

Quantifiable outcome

  • Consistently reduced time to payment and denial rates for supported products
  • +1 more outcomes

Companies that use OnPoint Oncology

Customer profile

Named customers4 records

Segments3 records

Ideal customer profiles2 records

OnPoint Oncology technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature3 records

OnPoint Oncology partnerships and signals

Strategic signal

Partnerships

One partnership is on record.

  • RXVantagecoreOthersRXVantage is the parent company of onPoint Oncology. onPoint Oncology operates as a division of RXVantage, leveraging shared technology platforms and organizational resources.

Scale indicators2 records

Recent moves7 records

Expansion highlights4 records

OnPoint Oncology competitors and assessment

Company assessment

Broad incumbents

  • IQVIA: IQVIA is the dominant healthcare data and analytics incumbent serving pharma with commercial effectiveness, market access, and real-world evidence solutions across all therapeutic areas including oncology.
  • Cencora (formerly AmerisourceBergen): Cencora operates specialty pharmaceutical distribution and data services (including legacy ION Solutions and Oncology Supply) — closely tied to buy-and-bill oncology reimbursement workflows and overlapping with onPoint's provider and pharma audiences.
  • Syneos Health: Syneos Health provides commercial and clinical services to pharma including market access and patient access support — adjacent to onPoint's pharma commercialization intelligence but with a broader service portfolio.
  • McKesson (US Oncology Network): McKesson operates the US Oncology Network and specialty distribution services for community oncology practices, including buy-and-bill workflow tools and manufacturer-facing analytics that overlap with onPoint's provider and pharma offerings.
  • Premier Inc. (PINC AI): Premier's PINC AI platform provides healthcare supply chain and clinical analytics; its specialty pharmacy and oncology benchmarking capabilities partially overlap with reimbursement and access analytics sold to pharma manufacturers.

Direct peers

  • MMIT (Managed Markets Insight & Technology): MMIT provides payer policy, formulary, and reimbursement intelligence to pharma manufacturers — directly overlapping focalPoint's core value proposition in market access data and coverage analytics. Both serve pharma access and reimbursement teams in oncology and specialty therapeutics.
  • ZS Associates: ZS Associates operates a large pharma access and launch excellence practice with proprietary data assets serving oncology brand commercialization, including reimbursement strategy consulting and analytics for buy-and-bill products.
  • Integra Connect: Integra Connect provides oncology practice management software, data analytics, and value-based care services to oncology practices and pharma manufacturers — overlapping with onPoint's provider-side buy-and-bill education and pharma intelligence offerings.

Emerging players

  • Flatiron Health: Flatiron Health is an oncology-specific EHR and real-world data company serving both academic research and pharma commercial use cases, providing overlapping oncology data infrastructure for life sciences customers.
  • ConcertAI: ConcertAI focuses on oncology real-world evidence and AI-driven clinical and commercial analytics for pharma and providers, partially overlapping with intelliPoint's market research and access strategy offerings.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat5 records

Key risks5 records

Key highlights6 records

Customer concentration

OnPoint Oncology social profiles

Digital presence

OnPoint Oncology financial estimates

Financial estimate

Revenue estimate

Valuation estimate

OnPoint Oncology leadership team

Management profile

Number of profiles

Profiles5 records

OnPoint Oncology funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

OnPoint Oncology M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about OnPoint Oncology

What does OnPoint Oncology do?

OnPoint Oncology develops and sells subscription-based software and data services that help biotech and pharmaceutical manufacturers, as well as oncology practices, navigate buy-and-bill oncology reimbursement. Its flagship product, focalPoint, provides real-time, web-based clearinghouse-level reimbursement intelligence on denials, payer policy, and payments for provider-administered oncology products, complemented by intelliPoint market research panels and the Buy and Bill Guide educational subscription.

Is OnPoint Oncology a public or private company?

OnPoint Oncology is a private company. It is classified as corporate owned and is currently operating.

When was OnPoint Oncology founded?

OnPoint Oncology was founded in 2008. It employs 1 to 10 people.

Where is OnPoint Oncology based?

OnPoint Oncology is headquartered in Hudson, United States, in the North America region.

How does OnPoint Oncology make money?

Three revenue lines are on record. focalPoint Subscription is the primary driver. The others are buy and Bill Guide and intelliPoint Market Research.

Who are OnPoint Oncology's main competitors?

Broad incumbents on record are IQVIA, Cencora (formerly AmerisourceBergen), Syneos Health, McKesson (US Oncology Network) and Premier Inc. (PINC AI). Direct peers are MMIT (Managed Markets Insight & Technology), ZS Associates and Integra Connect. Emerging players are Flatiron Health and ConcertAI.

Does OnPoint Oncology have an API?

No public API is recorded for OnPoint Oncology.

What industry is OnPoint Oncology in?

OnPoint Oncology's product category is Oncology Reimbursement Intelligence. Its primary akta.pro industry code is HLACAGAH, Oncology Pathways & Precision Medicine Decision Support, with a secondary code of HLACAEAI, Patient Financial Engagement (Estimates, Billing Presentment, Payments). Its NAICS code is 513210 and its SIC code is 7372.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals